BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18416131)

  • 1. [Hormonal and genotoxic aspects of BRCA1-associated carcinogenesis].
    Bershteĭn LM
    Vopr Onkol; 2007; 53(6):642-53. PubMed ID: 18416131
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis.
    Berstein LM
    Future Oncol; 2008 Feb; 4(1):23-39. PubMed ID: 18240998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
    Chlebowski RT
    Clin Breast Cancer; 2013 Jun; 13(3):159-66. PubMed ID: 23228361
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone receptors in breast carcinomas.
    Mandal AK
    Indian J Pathol Microbiol; 1995 Jan; 38(1):109-18. PubMed ID: 8919478
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems and solutions in the evaluation of hormone receptors in breast cancer.
    Allred DC
    J Clin Oncol; 2008 May; 26(15):2433-5. PubMed ID: 18487563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative endocrinology of familial and BRCA1-mediated breast cancer].
    Bershteĭn LM
    Vopr Onkol; 2009; 55(2):127-35. PubMed ID: 19514364
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucocorticoid receptor and breast cancer.
    Vilasco M; Communal L; Mourra N; Courtin A; Forgez P; Gompel A
    Breast Cancer Res Treat; 2011 Nov; 130(1):1-10. PubMed ID: 21818591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers.
    Osin P; Crook T; Powles T; Peto J; Gusterson B
    Lancet; 1998 May; 351(9114):1487. PubMed ID: 9605807
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical basis of breast cancer treatment by androgens and progestins.
    Rochefort H
    Prog Clin Biol Res; 1984; 142():79-95. PubMed ID: 6538685
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone treatment of breast cancer].
    Gröhn P
    Duodecim; 1991; 107(8):603-10. PubMed ID: 1364913
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
    Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
    Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R
    Cancer Res; 1978 Nov; 38(11 Pt 2):4299-304. PubMed ID: 698970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biomarkers of endocrine therapy-resistance in breast cancers].
    de Cremoux P; Debled M; Bonnefoi H; Cottu P
    Bull Cancer; 2010 Aug; 97(8):951-63. PubMed ID: 20605764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor: a never ending story?
    Wolff AC; Dowsett M
    J Clin Oncol; 2011 Aug; 29(22):2955-8. PubMed ID: 21709205
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal receptors in human neoplasia.
    Sandberg AA; Karr JP
    Int Adv Surg Oncol; 1980; 3():311-50. PubMed ID: 6256296
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
    Cappelletti V; Veneroni S; Coradini D; Oriana S; Tomasic G; Younes M; Daidone MG
    J Natl Cancer Inst; 2003 Apr; 95(8):629-30. PubMed ID: 12697859
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogen and progesterone receptors in carcinoma of the breast].
    Musiani P; Piantelli M; Dina MA
    Pathologica; 1979; 71(1011):1-7. PubMed ID: 450473
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dual effects of androgens on mammary gland].
    Brettes JP; Mathelin C
    Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal and progenotoxic properties of mammary fat in pre- and postmenopausal cancer patients].
    Bershteĭn LM; Kotov AV; Kovalevskiĭ AIu; Poroshina TE; Kovalenko IG; Tsyrlina EV; Semiglazov VF; Pozharisskiĭ KM
    Vopr Onkol; 2006; 52(5):505-10. PubMed ID: 17168356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progesterone receptor in breast cancer: fundamental data and clinical applications].
    Ojasoo T
    Bull Cancer; 1996; 83 Suppl 1():1-5. PubMed ID: 8777338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.